インテグリンベータ1の世界市場（～2026年）

• 英文タイトル：Global Integrin Beta 1 Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY01760 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はインテグリンベータ1のグローバル市場について調査・分析したレポートです。種類別（AXT-108、C-16Y、CLT-28643、SAL-021、その他）市場規模、用途別（遺伝性疾患、皮膚科、循環器、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別インテグリンベータ1の競争状況、市場シェア ・世界のインテグリンベータ1市場：種類別市場規模 2015年-2020年（AXT-108、C-16Y、CLT-28643、SAL-021、その他） ・世界のインテグリンベータ1市場：種類別市場規模予測 2021年-2026年（AXT-108、C-16Y、CLT-28643、SAL-021、その他） ・世界のインテグリンベータ1市場：用途別市場規模 2015年-2020年（遺伝性疾患、皮膚科、循環器、その他） ・世界のインテグリンベータ1市場：用途別市場規模予測 2021年-2026年（遺伝性疾患、皮膚科、循環器、その他） ・北米のインテグリンベータ1市場分析：米国、カナダ ・ヨーロッパのインテグリンベータ1市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのインテグリンベータ1市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のインテグリンベータ1市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのインテグリンベータ1市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Avipero Ltd、Clanotech AB、Morphic Therapeutic Inc、Strykagen Corp、Valeant Pharmaceuticals International Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Integrin Beta 1 Market
The global Integrin Beta 1 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Integrin Beta 1 Scope and Market Size
Integrin Beta 1 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Integrin Beta 1 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Integrin Beta 1 market is segmented into
AXT-108
C-16Y
CLT-28643
SAL-021
Others

Segment by Application, the Integrin Beta 1 market is segmented into
Genetic Disorders
Dermatology
Cardiovascular
Others

Regional and Country-level Analysis
The Integrin Beta 1 market is analysed and market size information is provided by regions (countries).
The key regions covered in the Integrin Beta 1 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Integrin Beta 1 Market Share Analysis
Integrin Beta 1 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Integrin Beta 1 business, the date to enter into the Integrin Beta 1 market, Integrin Beta 1 product introduction, recent developments, etc.

The major vendors covered:
Avipero Ltd
Clanotech AB
Morphic Therapeutic Inc
Strykagen Corp
Valeant Pharmaceuticals International Inc
…

レポート目次

---

1 Study Coverage
1.1 Integrin Beta 1 Product Introduction
1.2 Market Segments
1.3 Key Integrin Beta 1 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Integrin Beta 1 Market Size Growth Rate by Type
1.4.2 AXT-108
1.4.3 C-16Y
1.4.4 CLT-28643
1.4.5 SAL-021
1.4.6 Others
1.5 Market by Application
1.5.1 Global Integrin Beta 1 Market Size Growth Rate by Application
1.5.2 Genetic Disorders
1.5.3 Dermatology
1.5.4 Cardiovascular
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Integrin Beta 1 Market Size, Estimates and Forecasts
2.1.1 Global Integrin Beta 1 Revenue 2015-2026
2.1.2 Global Integrin Beta 1 Sales 2015-2026
2.2 Global Integrin Beta 1, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Integrin Beta 1 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Integrin Beta 1 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Integrin Beta 1 Competitor Landscape by Players
3.1 Integrin Beta 1 Sales by Manufacturers
3.1.1 Integrin Beta 1 Sales by Manufacturers (2015-2020)
3.1.2 Integrin Beta 1 Sales Market Share by Manufacturers (2015-2020)
3.2 Integrin Beta 1 Revenue by Manufacturers
3.2.1 Integrin Beta 1 Revenue by Manufacturers (2015-2020)
3.2.2 Integrin Beta 1 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Integrin Beta 1 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Integrin Beta 1 Revenue in 2019
3.2.5 Global Integrin Beta 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Integrin Beta 1 Price by Manufacturers
3.4 Integrin Beta 1 Manufacturing Base Distribution, Product Types
3.4.1 Integrin Beta 1 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Integrin Beta 1 Product Type
3.4.3 Date of International Manufacturers Enter into Integrin Beta 1 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Integrin Beta 1 Market Size by Type (2015-2020)
4.1.1 Global Integrin Beta 1 Sales by Type (2015-2020)
4.1.2 Global Integrin Beta 1 Revenue by Type (2015-2020)
4.1.3 Integrin Beta 1 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Integrin Beta 1 Market Size Forecast by Type (2021-2026)
4.2.1 Global Integrin Beta 1 Sales Forecast by Type (2021-2026)
4.2.2 Global Integrin Beta 1 Revenue Forecast by Type (2021-2026)
4.2.3 Integrin Beta 1 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Integrin Beta 1 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Integrin Beta 1 Market Size by Application (2015-2020)
5.1.1 Global Integrin Beta 1 Sales by Application (2015-2020)
5.1.2 Global Integrin Beta 1 Revenue by Application (2015-2020)
5.1.3 Integrin Beta 1 Price by Application (2015-2020)
5.2 Integrin Beta 1 Market Size Forecast by Application (2021-2026)
5.2.1 Global Integrin Beta 1 Sales Forecast by Application (2021-2026)
5.2.2 Global Integrin Beta 1 Revenue Forecast by Application (2021-2026)
5.2.3 Global Integrin Beta 1 Price Forecast by Application (2021-2026)

6 North America
6.1 North America Integrin Beta 1 by Country
6.1.1 North America Integrin Beta 1 Sales by Country
6.1.2 North America Integrin Beta 1 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Integrin Beta 1 Market Facts & Figures by Type
6.3 North America Integrin Beta 1 Market Facts & Figures by Application

7 Europe
7.1 Europe Integrin Beta 1 by Country
7.1.1 Europe Integrin Beta 1 Sales by Country
7.1.2 Europe Integrin Beta 1 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Integrin Beta 1 Market Facts & Figures by Type
7.3 Europe Integrin Beta 1 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Integrin Beta 1 by Region
8.1.1 Asia Pacific Integrin Beta 1 Sales by Region
8.1.2 Asia Pacific Integrin Beta 1 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Integrin Beta 1 Market Facts & Figures by Type
8.3 Asia Pacific Integrin Beta 1 Market Facts & Figures by Application

9 Latin America
9.1 Latin America Integrin Beta 1 by Country
9.1.1 Latin America Integrin Beta 1 Sales by Country
9.1.2 Latin America Integrin Beta 1 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Integrin Beta 1 Market Facts & Figures by Type
9.3 Central & South America Integrin Beta 1 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Integrin Beta 1 by Country
10.1.1 Middle East and Africa Integrin Beta 1 Sales by Country
10.1.2 Middle East and Africa Integrin Beta 1 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Integrin Beta 1 Market Facts & Figures by Type
10.3 Middle East and Africa Integrin Beta 1 Market Facts & Figures by Application

11 Company Profiles
11.1 Avipero Ltd
11.1.1 Avipero Ltd Corporation Information
11.1.2 Avipero Ltd Description and Business Overview
11.1.3 Avipero Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Avipero Ltd Integrin Beta 1 Products Offered
11.1.5 Avipero Ltd Related Developments
11.2 Clanotech AB
11.2.1 Clanotech AB Corporation Information
11.2.2 Clanotech AB Description and Business Overview
11.2.3 Clanotech AB Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Clanotech AB Integrin Beta 1 Products Offered
11.2.5 Clanotech AB Related Developments
11.3 Morphic Therapeutic Inc
11.3.1 Morphic Therapeutic Inc Corporation Information
11.3.2 Morphic Therapeutic Inc Description and Business Overview
11.3.3 Morphic Therapeutic Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Morphic Therapeutic Inc Integrin Beta 1 Products Offered
11.3.5 Morphic Therapeutic Inc Related Developments
11.4 Strykagen Corp
11.4.1 Strykagen Corp Corporation Information
11.4.2 Strykagen Corp Description and Business Overview
11.4.3 Strykagen Corp Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Strykagen Corp Integrin Beta 1 Products Offered
11.4.5 Strykagen Corp Related Developments
11.5 Valeant Pharmaceuticals International Inc
11.5.1 Valeant Pharmaceuticals International Inc Corporation Information
11.5.2 Valeant Pharmaceuticals International Inc Description and Business Overview
11.5.3 Valeant Pharmaceuticals International Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Valeant Pharmaceuticals International Inc Integrin Beta 1 Products Offered
11.5.5 Valeant Pharmaceuticals International Inc Related Developments
11.1 Avipero Ltd
11.1.1 Avipero Ltd Corporation Information
11.1.2 Avipero Ltd Description and Business Overview
11.1.3 Avipero Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Avipero Ltd Integrin Beta 1 Products Offered
11.1.5 Avipero Ltd Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Integrin Beta 1 Market Estimates and Projections by Region
12.1.1 Global Integrin Beta 1 Sales Forecast by Regions 2021-2026
12.1.2 Global Integrin Beta 1 Revenue Forecast by Regions 2021-2026
12.2 North America Integrin Beta 1 Market Size Forecast (2021-2026)
12.2.1 North America: Integrin Beta 1 Sales Forecast (2021-2026)
12.2.2 North America: Integrin Beta 1 Revenue Forecast (2021-2026)
12.2.3 North America: Integrin Beta 1 Market Size Forecast by Country (2021-2026)
12.3 Europe Integrin Beta 1 Market Size Forecast (2021-2026)
12.3.1 Europe: Integrin Beta 1 Sales Forecast (2021-2026)
12.3.2 Europe: Integrin Beta 1 Revenue Forecast (2021-2026)
12.3.3 Europe: Integrin Beta 1 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Integrin Beta 1 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Integrin Beta 1 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Integrin Beta 1 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Integrin Beta 1 Market Size Forecast by Region (2021-2026)
12.5 Latin America Integrin Beta 1 Market Size Forecast (2021-2026)
12.5.1 Latin America: Integrin Beta 1 Sales Forecast (2021-2026)
12.5.2 Latin America: Integrin Beta 1 Revenue Forecast (2021-2026)
12.5.3 Latin America: Integrin Beta 1 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Integrin Beta 1 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Integrin Beta 1 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Integrin Beta 1 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Integrin Beta 1 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Integrin Beta 1 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Integrin Beta 1 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Integrin Beta 1 Market Segments
Table 2. Ranking of Global Top Integrin Beta 1 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Integrin Beta 1 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AXT-108
Table 5. Major Manufacturers of C-16Y
Table 6. Major Manufacturers of CLT-28643
Table 7. Major Manufacturers of SAL-021
Table 8. Major Manufacturers of Others
Table 9. Global Integrin Beta 1 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Integrin Beta 1 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Integrin Beta 1 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Integrin Beta 1 Sales Market Share by Regions (2015-2020)
Table 13. Global Integrin Beta 1 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Integrin Beta 1 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Integrin Beta 1 Sales Share by Manufacturers (2015-2020)
Table 16. Global Integrin Beta 1 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Integrin Beta 1 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Integrin Beta 1 as of 2019)
Table 18. Integrin Beta 1 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Integrin Beta 1 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Integrin Beta 1 Price (2015-2020) (USD/Pcs)
Table 21. Integrin Beta 1 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Integrin Beta 1 Product Type
Table 23. Date of International Manufacturers Enter into Integrin Beta 1 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Integrin Beta 1 Sales by Type (2015-2020) (K Pcs)
Table 26. Global Integrin Beta 1 Sales Share by Type (2015-2020)
Table 27. Global Integrin Beta 1 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Integrin Beta 1 Revenue Share by Type (2015-2020)
Table 29. Integrin Beta 1 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Integrin Beta 1 Sales by Application (2015-2020) (K Pcs)
Table 31. Global Integrin Beta 1 Sales Share by Application (2015-2020)
Table 32. North America Integrin Beta 1 Sales by Country (2015-2020) (K Pcs)
Table 33. North America Integrin Beta 1 Sales Market Share by Country (2015-2020)
Table 34. North America Integrin Beta 1 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Integrin Beta 1 Revenue Market Share by Country (2015-2020)
Table 36. North America Integrin Beta 1 Sales by Type (2015-2020) (K Pcs)
Table 37. North America Integrin Beta 1 Sales Market Share by Type (2015-2020)
Table 38. North America Integrin Beta 1 Sales by Application (2015-2020) (K Pcs)
Table 39. North America Integrin Beta 1 Sales Market Share by Application (2015-2020)
Table 40. Europe Integrin Beta 1 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Integrin Beta 1 Sales Market Share by Country (2015-2020)
Table 42. Europe Integrin Beta 1 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Integrin Beta 1 Revenue Market Share by Country (2015-2020)
Table 44. Europe Integrin Beta 1 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Integrin Beta 1 Sales Market Share by Type (2015-2020)
Table 46. Europe Integrin Beta 1 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Integrin Beta 1 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Integrin Beta 1 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Integrin Beta 1 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Integrin Beta 1 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Integrin Beta 1 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Integrin Beta 1 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Integrin Beta 1 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Integrin Beta 1 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Integrin Beta 1 Sales Market Share by Application (2015-2020)
Table 56. Latin America Integrin Beta 1 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Integrin Beta 1 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Integrin Beta 1 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Integrin Beta 1 Revenue Market Share by Country (2015-2020)
Table 60. Latin America Integrin Beta 1 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Integrin Beta 1 Sales Market Share by Type (2015-2020)
Table 62. Latin America Integrin Beta 1 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Integrin Beta 1 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Integrin Beta 1 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Integrin Beta 1 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Integrin Beta 1 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Integrin Beta 1 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Integrin Beta 1 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Integrin Beta 1 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Integrin Beta 1 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Integrin Beta 1 Sales Market Share by Application (2015-2020)
Table 72. Avipero Ltd Corporation Information
Table 73. Avipero Ltd Description and Major Businesses
Table 74. Avipero Ltd Integrin Beta 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Avipero Ltd Product
Table 76. Avipero Ltd Recent Development
Table 77. Clanotech AB Corporation Information
Table 78. Clanotech AB Description and Major Businesses
Table 79. Clanotech AB Integrin Beta 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Clanotech AB Product
Table 81. Clanotech AB Recent Development
Table 82. Morphic Therapeutic Inc Corporation Information
Table 83. Morphic Therapeutic Inc Description and Major Businesses
Table 84. Morphic Therapeutic Inc Integrin Beta 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Morphic Therapeutic Inc Product
Table 86. Morphic Therapeutic Inc Recent Development
Table 87. Strykagen Corp Corporation Information
Table 88. Strykagen Corp Description and Major Businesses
Table 89. Strykagen Corp Integrin Beta 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Strykagen Corp Product
Table 91. Strykagen Corp Recent Development
Table 92. Valeant Pharmaceuticals International Inc Corporation Information
Table 93. Valeant Pharmaceuticals International Inc Description and Major Businesses
Table 94. Valeant Pharmaceuticals International Inc Integrin Beta 1 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Valeant Pharmaceuticals International Inc Product
Table 96. Valeant Pharmaceuticals International Inc Recent Development
Table 97. Global Integrin Beta 1 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 98. Global Integrin Beta 1 Sales Market Share Forecast by Regions (2021-2026)
Table 99. Global Integrin Beta 1 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 100. Global Integrin Beta 1 Revenue Market Share Forecast by Regions (2021-2026)
Table 101. North America: Integrin Beta 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 102. North America: Integrin Beta 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Europe: Integrin Beta 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 104. Europe: Integrin Beta 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Asia Pacific: Integrin Beta 1 Sales Forecast by Region (2021-2026) (K Pcs)
Table 106. Asia Pacific: Integrin Beta 1 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 107. Latin America: Integrin Beta 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. Latin America: Integrin Beta 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Middle East and Africa: Integrin Beta 1 Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Middle East and Africa: Integrin Beta 1 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 112. Key Challenges
Table 113. Market Risks
Table 114. Main Points Interviewed from Key Integrin Beta 1 Players
Table 115. Integrin Beta 1 Customers List
Table 116. Integrin Beta 1 Distributors List
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Integrin Beta 1 Product Picture
Figure 2. Global Integrin Beta 1 Sales Market Share by Type in 2020 & 2026
Figure 3. AXT-108 Product Picture
Figure 4. C-16Y Product Picture
Figure 5. CLT-28643 Product Picture
Figure 6. SAL-021 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Integrin Beta 1 Sales Market Share by Application in 2020 & 2026
Figure 9. Genetic Disorders
Figure 10. Dermatology
Figure 11. Cardiovascular
Figure 12. Others
Figure 13. Integrin Beta 1 Report Years Considered
Figure 14. Global Integrin Beta 1 Market Size 2015-2026 (US$ Million)
Figure 15. Global Integrin Beta 1 Sales 2015-2026 (K Pcs)
Figure 16. Global Integrin Beta 1 Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Integrin Beta 1 Sales Market Share by Region (2015-2020)
Figure 18. Global Integrin Beta 1 Sales Market Share by Region in 2019
Figure 19. Global Integrin Beta 1 Revenue Market Share by Region (2015-2020)
Figure 20. Global Integrin Beta 1 Revenue Market Share by Region in 2019
Figure 21. Global Integrin Beta 1 Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Integrin Beta 1 Revenue in 2019
Figure 23. Integrin Beta 1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Integrin Beta 1 Sales Market Share by Type (2015-2020)
Figure 25. Global Integrin Beta 1 Sales Market Share by Type in 2019
Figure 26. Global Integrin Beta 1 Revenue Market Share by Type (2015-2020)
Figure 27. Global Integrin Beta 1 Revenue Market Share by Type in 2019
Figure 28. Global Integrin Beta 1 Market Share by Price Range (2015-2020)
Figure 29. Global Integrin Beta 1 Sales Market Share by Application (2015-2020)
Figure 30. Global Integrin Beta 1 Sales Market Share by Application in 2019
Figure 31. Global Integrin Beta 1 Revenue Market Share by Application (2015-2020)
Figure 32. Global Integrin Beta 1 Revenue Market Share by Application in 2019
Figure 33. North America Integrin Beta 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Integrin Beta 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Integrin Beta 1 Sales Market Share by Country in 2019
Figure 36. North America Integrin Beta 1 Revenue Market Share by Country in 2019
Figure 37. U.S. Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Integrin Beta 1 Market Share by Type in 2019
Figure 42. North America Integrin Beta 1 Market Share by Application in 2019
Figure 43. Europe Integrin Beta 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Integrin Beta 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Integrin Beta 1 Sales Market Share by Country in 2019
Figure 46. Europe Integrin Beta 1 Revenue Market Share by Country in 2019
Figure 47. Germany Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Integrin Beta 1 Market Share by Type in 2019
Figure 58. Europe Integrin Beta 1 Market Share by Application in 2019
Figure 59. Asia Pacific Integrin Beta 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Integrin Beta 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Integrin Beta 1 Sales Market Share by Region in 2019
Figure 62. Asia Pacific Integrin Beta 1 Revenue Market Share by Region in 2019
Figure 63. China Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Integrin Beta 1 Market Share by Type in 2019
Figure 86. Asia Pacific Integrin Beta 1 Market Share by Application in 2019
Figure 87. Latin America Integrin Beta 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Integrin Beta 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Integrin Beta 1 Sales Market Share by Country in 2019
Figure 90. Latin America Integrin Beta 1 Revenue Market Share by Country in 2019
Figure 91. Mexico Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Integrin Beta 1 Market Share by Type in 2019
Figure 98. Latin America Integrin Beta 1 Market Share by Application in 2019
Figure 99. Middle East and Africa Integrin Beta 1 Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Integrin Beta 1 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Integrin Beta 1 Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Integrin Beta 1 Revenue Market Share by Country in 2019
Figure 103. Turkey Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Integrin Beta 1 Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Integrin Beta 1 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Integrin Beta 1 Market Share by Type in 2019
Figure 110. Middle East and Africa Integrin Beta 1 Market Share by Application in 2019
Figure 111. North America Integrin Beta 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Integrin Beta 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Integrin Beta 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Integrin Beta 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Integrin Beta 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Integrin Beta 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Integrin Beta 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Integrin Beta 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Integrin Beta 1 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Integrin Beta 1 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed

---